Want to join the conversation?
Generic pharmaceutical products maker $LCI said it plans to co-develop a generic insulin product for the US market with its Chinese partner, YiChang HEC ChangJiang Pharmaceutical Co., an HEC Group company. $LCI has the exclusive US marketing rights to the product, which is currently in late stage development.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$